In addition, the ROS may also induce the secretion of extracellular carriers and further enhance the production of IFN and IL-6 in macrophages, thereby inhibiting the immune response in the tumor microenvironment (21, 32, 33). The gene discussed is IL6; the disease is neoplasm.